Susquehanna International »

Lyell Immunopharma shares owned by Susquehanna International

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Susquehanna International from 13F filings

Historical chart of Susquehanna International investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Susquehanna International

Quarter filed Position value Share count Share price at filing
2025-09-30 $262k 16k 16.24
2025-06-30 $198k 22k 8.84

More positions owned by Susquehanna International

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Ishares Tr Russell 2000 Etf (IWM)
Amazon (AMZN)
UnitedHealth (UNH)
Netflix (NFLX)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Gold Tr Gold Shs (GLD)
Palantir Technologies Cl A (PLTR)
Broadcom (AVGO)

View all positions for Susquehanna International

Top funds holding Lyell Immunopharma

Arch Venture Corp
MWG Management
Foresite Capital Management IV
Vanguard Group
Orland Properties
Almitas Capital
Foresite Capital Management V
venBio Partners
Citadel Advisors
Alphabet
BlackRock
Sc China Holding
Geode Capital Management
Millennium Management
Rbf Capital

View all funds holding Lyell Immunopharma